Navigation Links
Agreement for Joint Trials of Avian Flu Vac cine on Humans

Sanofi Pasteur, the world's third-largest pharmaceutical firm together with the Public Health Ministry have reached an initial agreement to conduct joint trials on an avian flu vaccine, which could be used on humans early next year.//

According to Tawee Chotpitayasunondh, a member of the ministry's human avian flu study panel the vaccine trial is planned to be conducted on children aged six months to 18 years owing to the increased susceptibility of the young to a flu pandemic than adults.

Negotiations have been going on between the ministry and the firm following the abortion of the vaccine trial deal with Japan against the H5N1 strain of bird flu virus last month.

Following the meeting for the Influenza Pandemic Preparedness held in Pattaya, Dr Tawee asserted the need for further study on developing an H5N1 vaccine for humans because of the various forms that existed of the avian flu virus which could mean that a vaccine formula which was effective in Thailand and Vietnam might not be in Indonesia and China.

Medical director of sanofi pasteur, Sunate Chuenkitmongkol declared that the company planned to launch H5N1 vaccine trials on humans early next year.

The vaccine trials on children are expected to take around six months to a year. Approval for the project was also pending from the national committee on human vaccine trial ethics. Negotiations for a benefit-sharing agreement between the Public Health Ministry and the firm are also on.

Thailand would be the first country in Southeast Asia to conduct H5N1 vaccine trials on children following the approval.

Chuenkitmongkol said,''The vaccine trials aim to find proper doses of the vaccine to help the body to generate immunity against the disease. The trials will also let us know proper timing for vaccinations.''

In the meantime caretaker Prime Minister Thaksin Shinawatra has instructed health and livestock officials not to lower their g uard against bird flu.

Mr Thaksin stated that he did not want to see bird flu return again after the country had successfully controlled it and had earned recognition from the international community.


'"/>




Related medicine news :

1. Agreement To Speed Up Development of Bird flu vaccine
2. MIOT Hospital Signs Agreement With German Healthcare Facility
3. Strained Economic Agreement Between Singapore And India
4. Ranbaxy Signs Agreement With Zenotech For Cancer Drugs
5. Subsidies For GPs Visits : Agreement Reached
6. Ranbaxy Signs Licensing, Supply Agreement for Canadian Market
7. Indo-Fiji Agreement in Field of Health, Medicine Approved
8. Publishers John Wiley & Sons Enter Into An Agreement With NASPGHAN And AASLD
9. Medical Training Must Be Core Component Of Health Care Agreements
10. New Treatment For Hip Joints
11. Joint replacement surgery outcomes may be affected by obesity and diabetes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/6/2016)... , ... May 06, 2016 , ... ... arrival of Sovaldi, which made headlines mostly for its cost despite its potential ... and moral questions surrounding the drug—part of a class called direct-acting antivirals (DAAs)—have ...
(Date:5/6/2016)... ... 2016 , ... RowdMap, Inc. co-founder, Joshua Rosenthal, PhD, joins ... Deputy Administrator at Centers for Medicare and Medicaid Services (CMS); Ali Khan, MD, ... Officer at Health Care Service Corporation (Blue Cross and Blue Shield of Illinois, ...
(Date:5/5/2016)... Texas (PRWEB) , ... May 05, 2016 , ... ... the Responsible Wool Standard (RWS) for public stakeholder review. The stakeholder review is an ... that it meets its goals and delivers value to the wool industry., The RWS ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... This weekend, from Friday, May 6 - ... on steep California terrain at the first Team Semper Fi Mountain Bike Camp, hosted in ... will be mountain bike legends Mark Weir and Jason Moeschler, who’ll share pro tips with ...
(Date:5/5/2016)... Indianapolis, IN (PRWEB) , ... May 05, 2016 ... ... employee benefits advisory organization, announces McLaughlin & Smoak Benefits as the latest addition ... & Smoak Benefits has a dedicated team of compliance, wellness, human resources, and ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... , May 4, 2016 ... of Jerusalem announced today that it had signed ... BioTheryX, Inc. , developer of novel protein degradation and ... development and commercialization of drug candidates representing first-in-class therapy ... license were not disclosed. The novel technology ...
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Acute Myeloid Leukemia Market ... to their offering.       (Logo: ... Myeloid Leukemia Market and Competitive Landscape Highlights ... Leukemia pipeline products, Acute Myeloid Leukemia epidemiology, ...
(Date:5/3/2016)... 2016 Research and Markets has ... Cell Therapy Market Outlook 2020" report to their ... , ,Recombinant technology has improved significantly in past years ... developed in coming years. Many cancer drugs have been ... therapies are also expected to be developed with its ...
Breaking Medicine Technology: